endometrial thermoablation for treatment of menorrhagia

1
LETTER TO THE EDITOR Endometrial thermoablation for treatment of menorrhagia Acta Obstet Gynecol Scand 2003; 82: 1155. # Acta Obstet Gynecol Scand 82 2003 Sir, It has come to our attention that in the article by Dr Vihko and coworkers (Endometrial thermoablation for treatment of menorrhagia: comparison of two methods in outpatient setting. Acta Obstet Gynecol Scand 2003; 82: 269–74), certain points concerning the Cavaterm TM system and its use may be misleading. The original Cavaterm sys- tem in this study uses a circulating fluid of glycine 1.5% (nonconductive) heated to a target temperature of 75 C for a 15-min period. A pressure of 200–220mmHg should be maintained throughout the treatment. The correct combin- ation of pressure, temperature and time is essential for the success of the Cavaterm treatment. Optimal pressure is a key factor in the success rate and in particular in the amenorrhea rate as it ensures a reduction in the blood flow in the target tissue; otherwise the treatment is less than optimal. When the correct pressure of 200–220 mmHg is used in correctly selected patients, the Cavaterm’s pure amenorrhea rate is 58–68% (1, 2). Patient selection is also of the utmost importance. Wall- sten Medical SA recommends hydrosonography or hystero- scopy prior to the Cavaterm to rule out any cavity anomalies. Ultrasound may miss cavity anomalies that could inhibit the balloon from lying optimally against the entire endometrium. Sophie Belanger and Adam El Din References 1. Mettler L. Long-term results in the treatment of menorrhagia and hypermenorrhea with a thermal balloon endometrial ablation technique. JSLS 2002; 6: 305–9. 2. Hawe JA, Phillips G, Chien P, Erian J, Garry R. Cavaterm thermal balloon ablation for the treatment of menorrhagia. Br J Obstet Gynaecol 1999; 106: 1143–8. Address for correspondence: Sophie Belanger Wallsten Medical SA Box 2036 Avenue Riond-Bosson 14 CH-1110 Morges 2 Switzerland # Acta Obstet Gynecol Scand 82 (2003) Acta Obstet Gynecol Scand 2003: 82: 1155 Copyright # Acta Obstet Gynecol Scand 2003 Printed in Denmark. All rights reserved Acta Obstetricia et Gynecologica Scandinavica ISSN 0001-6349

Upload: sophie-belanger

Post on 06-Jul-2016

214 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Endometrial thermoablation for treatment of menorrhagia

LETTER TO THE EDITOR

Endometrial thermoablationfor treatment of menorrhagia

Acta Obstet Gynecol Scand 2003; 82: 1155. # Acta Obstet GynecolScand 82 2003

Sir,It has come to our attention that in the article by

Dr Vihko and coworkers (Endometrial thermoablation fortreatment of menorrhagia: comparison of two methods inoutpatient setting. Acta Obstet Gynecol Scand 2003; 82:269–74), certain points concerning the CavatermTM systemand its use may be misleading. The original Cavaterm sys-tem in this study uses a circulating fluid of glycine 1.5%(nonconductive) heated to a target temperature of 75 �C fora 15-min period. A pressure of 200–220 mmHg should bemaintained throughout the treatment. The correct combin-ation of pressure, temperature and time is essential for thesuccess of the Cavaterm treatment. Optimal pressure is a keyfactor in the success rate and in particular in the amenorrhearate as it ensures a reduction in the blood flow in the targettissue; otherwise the treatment is less than optimal. When thecorrect pressure of 200–220 mmHg is used in correctlyselected patients, the Cavaterm’s pure amenorrhea rate is58–68% (1, 2).

Patient selection is also of the utmost importance. Wall-sten Medical SA recommends hydrosonography or hystero-scopy prior to the Cavaterm to rule out any cavityanomalies. Ultrasound may miss cavity anomalies thatcould inhibit the balloon from lying optimally against theentire endometrium.

Sophie Belanger and Adam El Din

References

1. Mettler L. Long-term results in the treatment ofmenorrhagia and hypermenorrhea with a thermalballoon endometrial ablation technique. JSLS 2002;6: 305–9.

2. Hawe JA, Phillips G, Chien P, Erian J, Garry R.Cavaterm thermal balloon ablation for the treatmentof menorrhagia. Br J Obstet Gynaecol 1999; 106:1143–8.

Address for correspondence:Sophie BelangerWallsten Medical SABox 2036Avenue Riond-Bosson 14CH-1110 Morges 2Switzerland

# Acta Obstet Gynecol Scand 82 (2003)

Acta Obstet Gynecol Scand 2003: 82: 1155 Copyright # Acta Obstet Gynecol Scand 2003

Printed in Denmark. All rights reservedActa Obstetricia et

Gynecologica ScandinavicaISSN 0001-6349